Meriwether Wealth & Planning’s Quest Diagnostics DGX Stock Holding History

Meriwether Wealth & Planning’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.5K	Buy	+118	New	+$27.3K	0.01%	321

Other funds holding DGX

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Conning Inc Hartford, Connecticut $3.25B AUM 18.91% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Meriwether Wealth & Planning's DGX Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Quest Diagnostics (DGX) in Q3 2026: 118 shares worth $27.5K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings.

386 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Meriwether Wealth & Planning held 118 shares of Quest Diagnostics worth $27.5K as of Q3 2026.
Quest Diagnostics was a new Meriwether Wealth & Planning position in Q3 2026.
Quest Diagnostics made up 0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #321 holding.
386 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.